Harrow, Inc. (HROW)

52.84 -1.34 (-2.47%) USD  |  NASDAQ  |  Mar 02, 15:34
More

Harrow Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Xeris Biopharma Holdings, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade